The session will explore how oversight can move beyond passive review into a proactive quality function that integrates data analytics, trend detection, and structured follow up. Using real world examples, I will demonstrate how sponsors can identify and address early indicators of monitoring instability such as inconsistent visit cadence, delayed issue resolution, or CRA turnover through defined escalation pathways and targeted oversight visits.
Key takeaways will include:
- Building a practical Monitoring Oversight Plan aligned with ICH GCP E6(R3) expectations
- Using data visualization and KPI dashboards to evaluate CRO performance and site health
- Establishing feedback loops that turn oversight findings into continuous improvement actions
- Ensuring documentation meets regulatory standards for sponsor accountability and inspection readiness
Attendees will gain practical tools and insights for strengthening sponsor CRO collaboration, improving data quality, and demonstrating true oversight in an evolving regulatory landscape. The session is designed for sponsor and CRO professionals seeking scalable oversight models that enhance quality and efficiency across studies.
• Mitchell Hilbe - Director Clinical Operations, Expanded AccessDirector Clinical Operations - Expanded Access WideTrial, Inc.